Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Chemotherapy and Combination Anti-HIV Therapy for HIV-Associated Hodgkin's and Non-Hodgkin's Lymphoma

NCT00641381 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00641381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00641381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Chemotherapy and Combination Anti-HIV Therapy for HIV-Associated Hodgkin's and Non-Hodgkin's Lymphoma
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Completed
Start date
May 10, 2000
Completion date
February 13, 2026
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma